Global Veterinary Pain Management Market, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
“Global Veterinary Pain Management Market” is an upcoming market research report by MarketResearch.biz. The global veterinary pain management market segmentation allows for in-depth thought and understanding to decisively analyze, assess, and study. This is carried out using expert inputs and opinions, as well as extensive primary and secondary research efforts to ensure the accuracy of various findings on the global market. The global veterinary pain management research report is segmented on the basis of product, indication, end-use, animal type, and regions/countries.
Veterinary pain management is considered a vital part of veterinary therapeutics. Not addressing pain appropriately in sick animals may lead to exaggerated stress and delayed healing. The causes of pain in animals can be due to a host of reasons such as arthritis, cancer, surgeries, etc. Pain in animals can also be accompanied by aggression, and reduced or total loss of activity, etc. Pain in animals can also affect the productivity of both pets and farm animals. There are multiple options to treat the causes of pain in animals including laser therapy, medication, therapeutic massages, acupuncture, and physical rehabilitation.
Some of the major factors driving the global market’s growth are the growing awareness of better pet care and the increasing trend of pet adoption. Another factor that is anticipated to further fuel market growth over the coming years is pet obesity. As the Association for Pet Obesity Prevention (APOP) reported in 2017, 59% of cats and 56% of dogs in the US were categorized as being obese. Obesity in animals increases the risk of diabetes mellitus, cancer, joint diseases, and other chronic conditions. Obesity also puts canines at risk of cancer. Moreover, as reported by Kingsbrook vets in 2017, 20% of all pet dogs in the US were suffering from osteoarthritis, irrespective of their age. Another factor contributing to market growth is the increasing number of government organization initiatives to promote animal health. For instance, according to the European External Action Service (EEAS), European governments invested around $USD 4.7 million for animal healthcare in 2016. Rising investments in technological innovations & advancements and increasing pet adoption, as well as expenditure on pets, are projected to create growth opportunities for key players in the global veterinary pain management market over the years to come.
Global Veterinary Pain Management Market Segment Analysis:
By Product: The Nonsteroidal Anti-inflammatory Drugs (NSAIDs) segment accounted for the highest revenue and this is projected to continue over the next ten years. Nonsteroidal anti-inflammatory drugs are the most commonly used medication for inflammation and pain associated with osteoarthritis. Moreover, this segment’s growth can be attributed to stringent regulations by governments regarding the usage of opioids.
By Indication: The Osteoarthritis (OA) segment is expected to continue to account for the highest revenue share over the foreseeable future. This can be attributed to the increasing prevalence of this disease, especially in canines.
By Animal Type: The livestock animal segment accounted for the highest revenue share and is anticipated to continue to do so over the coming years. The growth of this segment can be attributed to the increasing awareness among animal healthcare organizations, higher incidences of chronic diseases, and growing animal healthcare spending, especially in developing countries.
Global Veterinary Pain Management Market Regional Analysis:
North America accounts for the highest revenue share and is projected to continue to do so over the next ten years. Market growth in the region can be attributed to the increasing demand for efficient animal care and a steady rise in the number of pet owners. In addition, well-established and highly developed animal healthcare facilities in the region are contributing to market growth.
Global Veterinary Pain Management Market Segmentation:
- Post-operative pain
By Animal Type:
- Livestock animal
- Companion Animal
By End Use:
- Hospitals & Clinics
- North America
- Asia Pacific
- South America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2019 Estimated Year 2020 Forecast Period 2020–2029 Revenue in US$
- Bayer AG
- Boehringer Ingelheim International GmbH
- Merck & Co. Inc.
- The Chanelle Group
- Norbrook Laboratories Limited
- Eli Lilly and Company Inc.
- Dechra Pharmaceuticals PLC.
- Ceva Sante Animale
- IDEXX Laboratories Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!